Status:
COMPLETED
Comparison Study of Two Supraglottic Airway Devices Used for Patients Under General Anesthesia
Lead Sponsor:
Maisonneuve-Rosemont Hospital
Conditions:
Anesthesia Airway Management
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will compare two supraglottic airway devices currently on the market. Supraglottic airway devices are used during general anesthesia to provide a patent airway. They are inserted blindly in...
Detailed Description
First of all, we will record the following demographic variables: age, sex, height, weight, BMI, surgery planned, American Society of Anesthesiology (ASA) status, dental state (good, bad, edentulous),...
Eligibility Criteria
Inclusion
- Weight more than 50 kg;
- Body Mass Index less than 30;
- ASA I to III.
Exclusion
- Symptomatic gastro oesophageal reflux disease (GERD);
- Non fasted patients;
- Nasogastric tube in place;
- Intestinal obstruction;
- Ear, nose and throat surgery in the past or deformation of the airway;
- Known difficult airway (Cormack-Lehane grade 3-4);
- Oral cavity opening less than 3 cm;
- Pregnancy.
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2011
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01001078
Start Date
September 1 2009
End Date
March 1 2011
Last Update
January 22 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Maisonneuve-Rosemont
Montreal, Quebec, Canada, H1T 2M4